I-Diethyl(3-pyridyl)borane CAS 89878-14-8 Ubumsulwa >99.0% (HPLC) I-Abiraterone Acetate Intermediate Factory

Incazelo emfushane:

Igama Lekhemikhali: Diethyl(3-pyridyl)borane

I-CAS: 89878-14-8

Ubumsulwa: >99.0% (HPLC)

Ukubukeka: Impushana Emhlophe

I-Intermediate ye-Abiraterone Acetate (CAS: 154229-18-2) yokwelashwa kwe-metastatic castration-resistant prostate cancer (mCRPC)

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Ukunikezwa Komkhiqizi, Ukuhlanzeka Okuphezulu, Ukukhiqizwa Kwezohwebo
Igama Lekhemikhali: Diethyl(3-pyridyl)borane
I-CAS: 89878-14-8

Chemical Properties:

Igama Lekhemikhali I-Diethyl (3-pyridyl) borane
Omqondofana 3-(Diethylboryl)pyridine
Inombolo ye-CAS 89878-14-8
Inombolo yeCAT I-RF-PI674
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula I-C9H14BN
Isisindo samangqamuzana 147.03
I-Melting Point 159.0~164.0℃ (okhanyisiwe)
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Impushana Emhlophe
I-Infrared Spectrum Ivumelana Nesakhiwo
Ukuhlanzeka / Indlela Yokuhlaziya >99.0% (HPLC)
Ukulahlekelwa Ekumisweni ≤0.50%
Izinsalela Ekushiseni ≤0.50%
Ukungcola Okukodwa ≤0.50%
Ukungcola Okuphelele <1.00%
Izinsimbi Ezisindayo (njenge-Pb) ≤20ppm
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Intermediate ye-Abiraterone Acetate (CAS: 154229-18-2)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

1

I-FAQ:

Isicelo:

I-Diethyl(3-pyridyl)borane (CAS: 89878-14-8) iphakathi kwe-Abiraterone Acetate (CAS: 154229-18-2).Ngo-April 2011, i-United States FDA igunyaze i-Abiraterone Acetate ngokuhambisana ne-steroid prednisone yokwelapha umdlavuza wendlala yesinye we-metastatic castration-resistant (mCRPC) ezigulini ezake zelashwa nge-docetaxel equkethe uhlobo lwesifo sesigaba sekwephuzile.Umuthi, owamakethwa ngaphansi kwegama lokuhweba elithi Zytiga, ekuqaleni watholwa abacwaningi baseCancer Research UK Center for Cancer Therapeutics ngo-1990, wathuthukiswa yiCougar Biotechnology, futhi wagcina uthengiswa uJohnson & Johnson ngemuva kokutholwa kwawo kweCougar ngo-2009.

Bhala umyalezo wakho lapha futhi usithumelele wona